These findings provide a substantial contribution to the already compelling evidence that plasma PAI-1 is an important clinical predictor of vascular stiffness, hypertension, and diastolic dysfunction, especially in individuals with obesity and diabetes. The gene discussed is SERPINE1; the disease is obesity due to melanocortin 4 receptor deficiency.